Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Quadruple Drug Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
New York, New York
This trial is testing a new cancer treatment in elderly patients with multiple myeloma who are not eligible for a transplant. The treatment consists of four drugs given in different combinations and doses. Patients will be monitored closely for side effects and how well the treatment works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service